Skip to main content

Table 3 Relation between abdominal fat and carotid atherosclerosis as determined by multiple linear regression analysis

From: Contribution of subcutaneous abdominal fat on ultrasonography to carotid atherosclerosis in patients with type 2 diabetes mellitus

  Men Women
(Adjusted-R2 = 0.396) (Adjusted-R2 = 0.262)
Variables Beta 95% CI P-value Beta 95% CI P-value
Age (years) 0.008 0.006 ~ 0.011 <0.001 0.007 0.004-0.009 <0.001
BMI (kg/m2) 0.007 -0.05 ~ 0.048 0.089 0.009 -0.004 ~ 0.021 0.175
SBP (mmHg) 0.001 0.000 ~ 0.002 0.098 0.001 -0.002 ~ 0.002 0.823
HDL-C (mg/dl) 0.001 -0.002 ~ 0.002 0.748 0.001 -0.002 ~ 0.004 0.424
LDL-C (mg/dl) 0.001 0.000 ~ 0.001 0.028 0.001 0.000 ~ 0.021 0.213
TG (mg/dl) 0.001 0.000 ~ 0.001 0.016 -0.001 0.000 ~ 0.001 0.766
HOMA-IR 0.001 -0.007 ~ 0.008 0.864 -0.006 -0.015 ~ 0.004 0.243
Smoking -0.001 -0.050 ~ 0.048 0.971 0.005 -0.147 ~ 0.158 0.946
Treatment with statin 0.007 -0.04 ~ 0.053 0.780 0.037 -0.021 ~ 0.094 0.206
Treatment with antihypertensive agents -0.003 -0.051 ~ 0.046 0.917 -0.036 -0.103 ~ 0.031 0.287
Treatment with TZD -0.06 -0.135 ~ 0.016 0.122 0.017 -0.089 ~ 0.123 0.75
VFT (mm) -0.001 -0.006 ~ 0.003 0.569 0.001 -0.006 ~ 0.007 0.835
SFT (mm) -0.004 -0.005 ~ -0.002 <0.001 -0.002 -0.005 ~ 0.001 0.175
  1. Abbreviations: BMI: body mass index; SBP: systolic blood pressure; HDL-C: high density lipoprotein-cholesterol; LDL-C: low density lipoprotein-cholesterol; TG: triglyceride; HOMA-IR: homeostasis model assessment-insulin resistance; TZD: thiazolidinedione; VFT: visceral fat thickness; SFT: subcutaneous fat thickness.